Web sitemizi kullanabilmek için javascript özelliğini etkinleştirmeniz gerekmektedir.

MPL Care (MPARK) 3Q25 Financial Results

Tacirler Investment

We evaluate MLP Healthcare’s 3Q25 financial results as neutral. We maintain our 12-month target price of TL 450 per share and our “HOLD” recommendation.

Detailed PDF   -   268 KB
Your transaction is being processed. Please wait.